Nephros, Inc. (NASDAQ:NEPH) Short Interest Up 133.7% in March

Nephros, Inc. (NASDAQ:NEPH) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 19,400 shares, a growth of 133.7% from the February 28th total of 8,300 shares. Based on an average daily trading volume, of 13,500 shares, the short-interest ratio is presently 1.4 days. Approximately 0.2% of the shares of the stock are sold short.

Hedge Funds Weigh In On Nephros

A hedge fund recently bought a new stake in Nephros stock. Topline Capital Management LLC acquired a new position in shares of Nephros, Inc. (NASDAQ:NEPH) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned approximately 3.98% of Nephros at the end of the most recent quarter. Institutional investors own 41.10% of the company’s stock.

Nephros Price Performance

Shares of Nephros stock remained flat at $1.67 during trading on Friday. 8,180 shares of the stock traded hands, compared to its average volume of 12,835. The stock has a market cap of $17.61 million, a P/E ratio of -18.56 and a beta of 1.19. Nephros has a 1-year low of $1.36 and a 1-year high of $2.55. The stock’s 50-day simple moving average is $1.57 and its 200 day simple moving average is $1.57.

Nephros (NASDAQ:NEPH) last posted its quarterly earnings results on Monday, March 24th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.04. Nephros had a negative return on equity of 11.39% and a negative net margin of 6.86%. The firm had revenue of $3.87 million for the quarter, compared to analyst estimates of $3.67 million.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.